These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 17666070)

  • 21. Reexamination of interictal psychoses based on DSM IV psychosis classification and international epilepsy classification.
    Kanemoto K; Tsuji T; Kawasaki J
    Epilepsia; 2001 Jan; 42(1):98-103. PubMed ID: 11207792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
    Harrow M; Jobe TH
    J Nerv Ment Dis; 2007 May; 195(5):406-14. PubMed ID: 17502806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathway followed by psychotic patients to a tertiary health center in a developing country: a comparison with patients with epilepsy.
    Razali SM; Mohd Yasin MA
    Epilepsy Behav; 2008 Aug; 13(2):343-9. PubMed ID: 18514034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients.
    Shiloh R; Schapir L; Bar-Ziv D; Stryjer R; Konas S; Louis R; Hermesh H; Munitz H; Weizman A; Valevski A
    Eur Neuropsychopharmacol; 2009 Sep; 19(9):654-8. PubMed ID: 19493658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief reactive psychosis and the major functional psychoses: descriptive case studies in Africa.
    Guinness EA
    Br J Psychiatry Suppl; 1992 Apr; (16):24-41. PubMed ID: 1389028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia.
    de Haan L; Nimwegen Lv; Amelsvoort Tv; Dingemans P; Linszen D
    Pharmacopsychiatry; 2008 Jul; 41(4):125-8. PubMed ID: 18651339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
    Novak Sarotar B; Pesek MB; Agius M; Kocmur M
    Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients].
    Loas G; Azi A; Noisette C; Yon V
    Encephale; 2008 Jan; 34(1):54-60. PubMed ID: 18514151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
    Taylor D; Hayhurst K; Kerwin R
    Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Improvement criteria after neuroleptic treatment and clinical and neuroradiological factors in schizophrenic psychoses. Preliminary studies].
    Jarema M; Choma M; Poniatowska R; Krawczyk R; Kozłowski P
    Psychiatr Pol; 1997; 31(1):21-32. PubMed ID: 9527652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duloxetine treatment of major depressive episodes in the course of psychotic disorders.
    Zink M; Knopf U; Mase E; Kuwilsky A; Deuschle M
    Pharmacopsychiatry; 2006 May; 39(3):109-11. PubMed ID: 16721699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epileptic peri-ictal psychosis, a reversible cause of psychosis.
    González Mingot C; Gil Villar MP; Calvo Medel D; Corbalán Sevilla T; Martínez Martínez L; Iñiguez Martínez C; Santos Lasaosa S; Mauri Llerda JA
    Neurologia; 2013 Mar; 28(2):81-7. PubMed ID: 22703628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interictal psychotic episodes in epilepsy: duration and associated clinical factors.
    Adachi N; Akanuma N; Ito M; Okazaki M; Kato M; Onuma T
    Epilepsia; 2012 Jun; 53(6):1088-94. PubMed ID: 22429239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of comprehensive supports for schizophrenic women during pregnancy and puerperium: preliminary study.
    Nishizawa O; Sakumoto K; Hiramatsu K; Kondo T
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):665-71. PubMed ID: 18081629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacologic treatment of the psychotic symptoms in schizophrenia].
    Goldchluk A
    Vertex; 2002; 13 Suppl 1():4-11. PubMed ID: 12122421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM; Smith L
    Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.